AUPH
$17.33+2.54%
Aurinia Pharmaceuticals IncStock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.003% of IWV
AUPH financial statements
The full income statement, balance sheet, and cash-flow statement for Aurinia Pharmaceuticals Inc (AUPH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 143.0M2024-09 143.2M2024-12 137.3M2025-03 135.1M2025-06 131.6M2025-09 131.8M2025-12 133.0M2026-03 128.6M2026-06 133.1M-7.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 283M+20.4% | 235M+34.0% | 176M+31.0% | 134M+193.9% | 45.6M-9.0% | |
| Cost of revenue | 32.7M+15.6% | 28.2M+99.7% | 14.1M+149.8% | 5.66M+419.2% | 1.09M | |
| 178M-25.7% | 240M-10.2% | 267M | — | — | ||
| Research & development | 32.5M+56.4% | 20.8M-58.1% | 49.6M+10.3% | 45.0M-12.0% | 51.1M+1.6% | |
| Selling, general & administrative | 102M-40.8% | 172M-11.8% | 195M-0.7% | 196M+13.2% | 174M+78.3% | |
| General & administrative | 102M-40.8% | 172M-11.8% | 195M-0.7% | 196M+13.2% | 174M+78.4% | |
| Amortization of intangibles | 800K-11.1% | 900K-47.1% | 1.70M-19.0% | 2.10M+0.0% | 2.10M+61.5% | |
| Operating income | 105M+2338.4% | -4.69M+94.9% | -91.7M+17.7% | -111M+38.3% | -181M-73.3% | |
| Interest expense | 4.33M-10.4% | 4.83M+74.2% | 2.77M | 0.00 | 0.00 | |
| Interest & investment income | 13.6M-20.0% | 17.0M-0.2% | 17.0M+232.1% | 5.12M | — | |
| Pre-tax income | 114M+1432.7% | 7.45M+109.6% | -77.5M+27.2% | -106M+41.0% | -180M-75.3% | |
| Income tax | -173M-10303.1% | 1.70M+207.8% | 551K-69.9% | 1.83M+140.5% | 760K+908.5% | |
| Net income | 287M+4893.1% | 5.75M+107.4% | -78.0M+27.9% | -108M+40.2% | -181M-76.2% | |
| $2.07+5075.0% | $0.04+107.4% | -$0.54+28.9% | -$0.76+45.7% | -$1.40-60.9% | ||
| EPS (basic) | $2.14+5250.0% | $0.04+107.4% | -$0.54+28.9% | -$0.76+45.7% | -$1.40-60.9% | |
| Weighted-avg shares (basic) | 134M-6.1% | 143M-0.1% | 143M+0.9% | 142M+9.7% | 129M+9.2% | |
| Weighted-avg shares (diluted) | 139M-5.1% | 146M+2.1% | 143M+0.9% | 142M+9.7% | 129M+9.2% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 492M+10.2% | 447M+5.1% | 425M-4.0% | 443M-13.8% | 513M+22.4% | ||
| Cash & equivalents | 80.2M-3.9% | 83.4M+71.1% | 48.8M-48.2% | 94.1M-59.4% | 232M-14.9% | |
| Inventory | 45.7M+16.5% | 39.2M-1.2% | 39.7M+60.4% | 24.8M+28.1% | 19.3M+38.8% | |
| Prepaid expenses | — | — | 9.49M-30.1% | 13.6M+8.6% | 12.5M+74.4% | |
| Other current assets | 1.08M-4.3% | 1.13M+9.5% | 1.03M-22.7% | 1.33M+67.6% | 796K-21.8% | |
| 752M+36.5% | 551M+0.5% | 548M+16.4% | 471M-13.3% | 543M+17.2% | ||
| Property, plant & equipment | 2.11M-22.7% | 2.73M-18.6% | 3.35M-8.1% | 3.65M-17.4% | 4.42M-7.7% | |
| Operating lease right-of-use | 3.60M-11.6% | 4.07M-9.6% | 4.50M-8.3% | 4.91M-8.8% | 5.38M-1.9% | |
| Intangible assets | 3.76M-13.6% | 4.36M-12.5% | 4.98M-22.5% | 6.42M-23.5% | 8.40M-9.9% | |
| Deferred tax assets | 176M | 0.00 | — | — | — | |
| Other non-current assets | 93.0K-88.7% | 823K-45.7% | 1.52M-88.6% | 13.3M+12.7% | 11.8M+4692.7% | |
| 93.7M-4.1% | 97.8M+26.7% | 77.2M+67.4% | 46.1M+13.4% | 40.6M+27.0% | ||
| Accounts payable | 3.31M-36.1% | 5.19M+19.9% | 4.33M+40.2% | 3.09M-20.4% | 3.88M+47.2% | |
| Accrued liabilities | 66.6M+2.5% | 65.0M+29.8% | 50.1M+25.2% | 40.0M+14.4% | 34.9M+40.9% | |
| Deferred revenue | 3.72M-66.2% | 11.0M+128.6% | 4.81M+52.9% | 3.15M+1556.8% | 190K | |
| Current lease liability | 1.07M+4.0% | 1.03M+3.7% | 989K+5.7% | 936K-11.6% | 1.06M+34.4% | |
| Other current liabilities | 2.48M+62.0% | 1.53M-35.9% | 2.39M+17.5% | 2.03M-54.3% | 4.45M-30.6% | |
| Finance lease liability (current) | 16.5M+17.6% | 14.0M-3.9% | 14.6M | 0.00 | — | |
| 170M-1.7% | 173M+1.8% | 170M+160.0% | 65.4M+1.8% | 64.3M+15.0% | ||
| Deferred revenue (non-current) | 12.6M+644.4% | 1.70M | — | — | — | |
| Non-current lease liability | 4.90M-14.7% | 5.74M-12.1% | 6.53M-8.7% | 7.15M-6.9% | 7.68M+0.8% | |
| Operating lease liability (total) | 5.97M-11.8% | 6.77M-10.0% | 7.52M-7.0% | 8.09M-7.4% | 8.74M+3.9% | |
| Finance lease liability (total) | 68.8M-5.2% | 72.6M-19.4% | 90.1M | — | — | |
| Finance lease liability | 52.3M-10.6% | 58.6M-22.4% | 75.5M | 0.00 | — | |
| Deferred tax liabilities | 0.00 | — | — | — | — | |
| Other non-current liabilities | 6.66M-29.1% | 9.40M-13.8% | 10.9M-10.3% | 12.2M-23.7% | 15.9M-2.1% | |
| 581M+54.0% | 377M-0.1% | 378M-6.8% | 405M-15.4% | 479M+17.5% | ||
| Additional paid-in capital | 111M-12.4% | 127M+5.1% | 121M+41.3% | 85.5M+44.9% | 59.0M+49.8% | |
| Retained earnings | -649M+30.7% | -937M+0.6% | -942M-9.0% | -864M-14.3% | -756M-31.5% | |
| Accumulated other comprehensive income | -599K+7.4% | -647K+11.4% | -730K+31.2% | -1.06M-24.5% | -852K-5.8% | |
| Total liabilities & equity | 752M+36.5% | 551M+0.5% | 548M+16.4% | 471M-13.3% | 543M+17.2% | |
| Common shares issued | 132M-6.1% | 141M-2.1% | 144M+1.1% | 142M+0.5% | 142M+11.8% | |
| Common shares outstanding | 132M-6.1% | 141M-2.1% | 144M+1.1% | 142M+0.5% | 142M+11.8% | |
| Shares outstanding (cover) | 133M-3.2% | 137M-5.0% | 145M+1.4% | 143M+0.7% | 142M+11.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 136M+205.6% | 44.4M+232.7% | -33.5M+57.9% | -79.5M+49.6% | -158M-125.7% | ||
| Depreciation & amortization | 19.4M+0.0% | 19.4M+67.0% | 11.6M+330.4% | 2.71M-2.1% | 2.76M+99.9% | |
| Intangible amortization | 800K-11.1% | 900K-47.1% | 1.70M-19.0% | 2.10M+0.0% | 2.10M+61.5% | |
| Share-based compensation | 14.7M-53.5% | 31.6M-30.3% | 45.3M+40.3% | 32.3M+3.4% | 31.2M+79.0% | |
| Deferred income taxes | -176M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in inventory | 6.46M+1454.7% | -477K-103.0% | 15.9M+74.9% | 9.07M+60.7% | 5.64M-59.5% | |
| Change in payables | -1.87M-317.9% | 860K-30.6% | 1.24M+256.6% | -792K | — | |
| -32.8M-183.5% | 39.3M+685.5% | -6.71M+88.9% | -60.6M+41.6% | -104M+34.3% | ||
| Capital expenditure | 252K-10.3% | 281K-60.9% | 718K+145.9% | 292K-3.6% | 303K-94.7% | |
| Free cash flow | 135M+207.0% | 44.1M+229.0% | -34.2M+57.2% | -79.8M+49.5% | -158M-109.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -106M-116.1% | -49.1M-857.0% | -5.13M-310.9% | 2.43M-98.9% | 221M+13.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 756K-30.3% | 1.08M-41.4% | 1.85M-3.2% | 1.91M-99.0% | 197M+4.8% | |
| Common stock repurchased | 98.2M+143.9% | 40.2M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -3.22M-109.3% | 34.6M+176.3% | -45.3M+67.1% | -138M-240.5% | -40.5M-20.1% | |
| Income taxes paid | 2.82M+28.9% | 2.18M+340.3% | 496K-74.9% | 1.98M+670.0% | 257K-1.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.12B+72.0% | 1.23B-4.5% | 1.29B+110.3% | 614M-81.0% | 3.24B+83.8% | |
| P/E | 7.4×-96.6% | 214.4× | — | — | — | |
| P/S | 7.5×+42.9% | 5.2×-35.5% | 8.1×+70.8% | 4.8×-93.3% | 71.0×+102.0% | |
| P/B | 3.6×+11.7% | 3.3×-0.8% | 3.3×+127.2% | 1.4×-78.6% | 6.8×+56.4% | |
| P/FCF | 15.7×-44.0% | 28.0× | — | — | — | |
| Earnings yield | 13.5%+2803.5% | 0.47% | — | — | — | |
| FCF yield | 6.4%+78.5% | 3.6% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AUPH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AUPH filings on SEC EDGAR → Not investment advice.